In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients
- 31 August 2012
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 40 (2), 173-176
- https://doi.org/10.1016/j.ijantimicag.2012.04.006
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Quantitative Test of Population Genetics Using Spatiogenetic Patterns in Bacterial ColoniesThe American Naturalist, 2011
- Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem on Mucoid and Nonmucoid Pseudomonas aeruginosa BiofilmsAntimicrobial Agents and Chemotherapy, 2011
- Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infectionPediatric Pulmonology, 2010
- Early Eradication of Pseudomonas aeruginosa in Patients with Cystic FibrosisPaediatric Respiratory Reviews, 2010
- Pharmacokinetics of inhaled colistin in patients with cystic fibrosisJournal of Antimicrobial Chemotherapy, 2006
- Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolates Derived from Patients with Cystic Fibrosis under Aerobic, Anaerobic, and Biofilm ConditionsJournal of Clinical Microbiology, 2005
- Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patientsClinical Microbiology & Infection, 2005
- Early intervention and prevention of lung disease in cystic fibrosis: a European consensusJournal of Cystic Fibrosis, 2004
- Clinically Feasible Biofilm Susceptibility Assay for Isolates of Pseudomonas aeruginosa from Patients with Cystic FibrosisJournal of Clinical Microbiology, 2004
- Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'Nature Reviews Microbiology, 2004